Swedish Orphan Biovitrum Ab (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIOVF | AMGN | BMY | VRTX | GILD |
| Company | Swedish Orphan Biovitrum Ab | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 28.3000 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 28.3000 | 291.11 | 58.48 | 455.43 | 89.94 |
| Low | 28.3000 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 28.3000 | 289.90 | 58.23 | 450.37 | 89.76 |
| Change | -3.0800 | +2.03 | +0.35 | -0.86 | +1.13 |
| % Change | -9.82% | +0.71% | +0.60% | -0.19% | +1.27% |
| Volume | 200 | 2,894,494 | 7,270,835 | 1,435,626 | 3,722,089 |
| 20-Day Average Volume | 1,005 | 2,840,502 | 12,273,399 | 1,319,064 | 7,439,888 |
| Previous Close | 31.3800 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 28.0941 | 307.43 | 55.92 | 479.21 | 90.89 |
| 20-Day Raw Stochastic | 57.89% | 27.67% | 69.42% | 6.42% | 28.47% |
| 20-Day Relative Strength | 52.56% | 36.69% | 60.74% | 40.77% | 53.52% |
| Weighted Alpha | N/A | +2.04 | +26.09 | +17.90 | +26.01 |
| Today's Opinion | N/A | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | N/A | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | N/A | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.60% since 09/20/24 | -1.96% since 11/14/24 | -0.44% since 11/14/24 | -7.03% since 11/14/24 | -2.58% since 11/14/24 |
| Low | 28.3000 on 11/18/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 32.0100 on 10/25/24 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | -4.07% since 10/03/24 | -8.40% since 10/21/24 | +11.75% since 10/21/24 | -5.89% since 10/21/24 | +3.99% since 10/21/24 |
| Low | 28.3000 on 11/18/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 32.0100 on 10/25/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +17.55% since 08/05/24 | -11.85% since 08/21/24 | +20.24% since 08/21/24 | -7.44% since 08/21/24 | +19.43% since 08/21/24 |
| Low | 28.3000 on 11/18/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 32.2500 on 09/17/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +9.88% since 05/03/24 | -7.85% since 05/21/24 | +37.79% since 05/21/24 | +1.79% since 05/21/24 | +33.35% since 05/21/24 |
| Low | 24.0750 on 08/05/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 32.2500 on 09/17/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,353,028 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 295,160 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 2,086,200,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | 227,170,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 508,280,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | 20,920,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.56 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.07 on 07/16/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/25/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 46.15 | 14.57 | 49.77 | 0.00 | 19.81 |